References
- Aoki Y. Protective action of OK-432 (picibanil) on the radiation-induced myelosuppression. Nippon Acta Radiologica 1986; 46: 1324–1330, (in Japanese)
- Bond V.P., Fliedner T.M., Archamberau J.O. Cytokinetics and radiation induced lethality. Mammalian Radiation Lethality. Academie Press, New York 1965; 231–275
- Brook I. Use of antibiotics in the management of post irradiation wound infection and sepsis. Radiation Research 1988; 115: 1–25
- Brook I., MacVittie T.J., Walker R.I. Recovery of aerobic and anaerobic bacteria from irradiated mice. Infection and Immunity 1984; 46: 270–271
- Brook I., Walker R.I., MacVittie T.J. Effect of antimicrobial therapy on bowel flora and bacterial infection in irradiated mice. International Journal of Radiation Biology 1988; 53: 709–716
- Brook I., Elliot T.B. Quinolone therapy in the prevention of mortality after irradiation. Radiation Research 1991; 128: 100–103
- Fass R.J. In vitro activity of ciprofloxacin (BAY o 9867). Antimicrobiotics and Agents in Chemotherapy 1983; 24: 568–574
- Gale R.P. Immediate medical consequences of nuclear accidents: lessons from chernobyl. Journal of the American Medical Association 1987; 285: 625–628
- Hammond C.W., Vogel H.H., Clark H.W., Cooper D.B., Miller C.P. The effect of streptomycin therapy in mice irradiated with fast neutrons. Radiation Research 1953; 2: 359–360
- Hammond C.W. The treatment of post-irradiation infection. Radiation Research 1954; 1: 448–458
- Hiraoka A., Yamagishi M., Ohkubo T., Kamamoto T., Yoshida Y., Uchino H. Effect of a strepto-coccal preparation, OK-432, on hematopoietic spleen colony formation in irradiated mice. Cancer Research 1981; 41: 2954–2958
- Hoshino T., Uchida A. OK-432 (picibanil): property, action and clinical effectiveness. Clinical and Experimental Studies in Immunotherapy, T. Hoshino, A. Uchida. Excerpta Medica, Tokyo 1984; 1–19
- Kitoh K., Katsu K., Satoh M., Sugihara Y., Watanabe N., Toyosawa T., Moriyama M. Aztreonam, a new monocyclic beta-lactam antibiotic: in vitro and in vivo antibacterial activities. Chemotherapy 1985; 33(S-1)87–114
- Kurishita A., Katoh H., Uehara Y., Uchida A., Mizutani Y., Ono T., Hirose S., Okada S. Post-irradiation treatment with OK432 can prevent radiation-induced bone marrow death. International Journal of Radiation Biology 1991; 59: 711–716
- Manual of Clinical Mictobiology4th edn, E.H. Lennette, A. Balows, W.J. Hausler, H.J. Shadomy. American Society Microbiology, Washington, DC 1985
- Miller C.P., Hammond C.W., Tompkins M.J., Shorter G. The treatment of post-irradiation infection with antibiotics, an experimental study on mice. Journal of Laboratory and Clinical Medicine 1952; 39: 462–479
- Mitsuhashi S., Inoue M. In vitro antibacterial activity of aztreonam. Chemotherapy 1985; 33(S-1)1–13
- Sawa K., Aoki M., Bunai M., Kagawa K., Watanabe K., Ueno K. Antimicrobial activity of azthreonam against anaerobic bacteria. Chemotherapy 1985; 33: 75–86
- Sykes R.B. Aztreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic Gramnegative bacteria. Antimicrobiol Agents in Chemotherapy 1982; 21: 85–92
- Vincent J.B., Veomett R.C., Riley R.F. Relation of the indigenous flora of the small intestine of the rat to post-irradiation bacteria. Journal of Bacteriology 1955; 69: 38–44
- Wensinck F., Renaud H. Bacteraemia in irradiated mice. British Journal of Experimental Pathology 1957; 38: 483–488